Researchers presented the proof-of-concept of a pathogen Air Quality (pAQ) monitor.
Atezolizumab Plus Carboplatin Boosts Survival in Metastatic TNBC
Adding atezolizumab (Tecentriq) to carboplatin improved progression-free survival (PFS) and overall survival (OS) in patients with metastatic triple-negative breast cancer (TNBC), according to results of